ClinicalTrials.Veeva

Menu

Safety and Performance of a New Coating for Urinary Intermittent Catheters

Coloplast logo

Coloplast

Status

Completed

Conditions

Intermittent Urethral Catheterization

Treatments

Device: ZN-D catheter
Device: SpeediCath catheter
Device: ZN-C catheter

Study type

Interventional

Funder types

Industry

Identifiers

NCT01800903
CP235 (Other Identifier)

Details and patient eligibility

About

The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.

Enrollment

40 patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Have given written informed consent and signed letter of authority
  2. Be at least 18 years of age and have full legal capacity
  3. Be a male
  4. Willing to refrain from using analgetics up to 24 hours prior to catheterization visits

Exclusion criteria

  1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract
  2. Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)
  3. Participating in other interventional clinical investigations during this investigation (inclusion to termination) or have previously participated in this investigation (including run-in period)
  4. Known hypersensitivity toward any of the test products -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

40 participants in 6 patient groups

Sequence 1
Active Comparator group
Description:
SpeediCath catheter then ZN-D catheter then ZN-C catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter
Sequence 2
Experimental group
Description:
SpeediCath catheter then ZN-C catheter then ZN-D catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter
Sequence 3
Experimental group
Description:
ZN-D catheter then SpeediCath catheter then ZN-C catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter
Sequence 4
Experimental group
Description:
ZN-D catheter then ZN-C catheter then SpeediCath catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter
Sequence 5
Experimental group
Description:
ZN-C catheter then SpeediCath catheter then ZN-D catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter
Sequence 6
Experimental group
Description:
ZN-C catheter then ZN-D catheter then SpeediCath catheter
Treatment:
Device: SpeediCath catheter
Device: ZN-D catheter
Device: ZN-C catheter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems